Global Nuclear Receptor ROR-Gamma Market Analysis 2013-2018 and Forecast 2019-2024
December 2018
107
About the Report
About the Report
Snapshot
The global Nuclear Receptor ROR-Gamma market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Nuclear Receptor ROR-Gamma by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
VPR-66
INV-17
GSK-2981278
BBI-6000
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
4SC AG
Advinus Therapeutics Ltd.
Arrien Pharmaceuticals, LLC
Aurigene Discovery Technologies Limited
Biogen, Inc.
Brickell Biotech, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech, Inc.
Genfit SA
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
Karo Bio AB
Lead Pharma Holding B.V.
Nuevolution AB
Phenex Pharmaceuticals AG
Reata Pharmaceuticals, Inc.
Teijin Pharma Limited
Visionary Pharmaceuticals, Inc.
Vitae Pharmaceuticals, Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Products
Table of Contents
Table of Contents
Table of Content
1 Industry Overview
1.1 Nuclear Receptor ROR-Gamma Industry
1.1.1 Overview
1.1.2 Development of Nuclear Receptor ROR-Gamma
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Nuclear Receptor ROR-Gamma Market by Type
3.1 By Type
3.1.1 VPR-66
3.1.2 INV-17
3.1.3 GSK-2981278
3.1.4 BBI-6000
3.1.5 Others
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.1 4SC AG (Company Profile, Sales Data etc.)
4.2 Advinus Therapeutics Ltd. (Company Profile, Sales Data etc.)
4.3 Arrien Pharmaceuticals, LLC (Company Profile, Sales Data etc.)
4.4 Aurigene Discovery Technologies Limited (Company Profile, Sales Data etc.)
4.5 Biogen, Inc. (Company Profile, Sales Data etc.)
4.6 Brickell Biotech, Inc. (Company Profile, Sales Data etc.)
4.7 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
4.8 Celgene Corporation (Company Profile, Sales Data etc.)
4.9 Genentech, Inc. (Company Profile, Sales Data etc.)
4.10 Genfit SA (Company Profile, Sales Data etc.)
4.11 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.12 Hanmi Pharmaceuticals, Co. Ltd. (Company Profile, Sales Data etc.)
4.13 Karo Bio AB (Company Profile, Sales Data etc.)
4.14 Lead Pharma Holding B.V. (Company Profile, Sales Data etc.)
4.15 Nuevolution AB (Company Profile, Sales Data etc.)
4.16 Phenex Pharmaceuticals AG (Company Profile, Sales Data etc.)
4.17 Reata Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.18 Teijin Pharma Limited (Company Profile, Sales Data etc.)
4.19 Visionary Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.20 Vitae Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Market Demand
6.1 Demand Situation
6.1.1 Demand in Hospital
6.1.2 Demand in Clinic
6.1.3 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
List of Figure
Figure Nuclear Receptor ROR-Gamma Industry Chain Structure
Figure Global Nuclear Receptor ROR-Gamma Market Growth 2013-2018, by Type, in USD Million
Figure North America Nuclear Receptor ROR-Gamma Market, by Company, in 2018
Figure Europe Nuclear Receptor ROR-Gamma Market Market, by Company, in 2018
Figure Asia-Pacific Nuclear Receptor ROR-Gamma Market Market, by Company, in 2018
Figure South America Nuclear Receptor ROR-Gamma Market Market, by Company, in 2018
Figure Middle East & Africa Nuclear Receptor ROR-Gamma Market Market, by Company, in 2018
Figure North America Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million
Figure Europe Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million
Figure South America Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Nuclear Receptor ROR-Gamma Market Size and Growth 2013-2018, in USD Million
Figure Marketing Channels Overview
List of Table
Table Upstream Segment of Nuclear Receptor ROR-Gamma
Table Application Segment of Nuclear Receptor ROR-Gamma
Table Global Nuclear Receptor ROR-Gamma Market 2013-2024, by Application, in USD Million
Table Major Company List of VPR-66
Table Major Company List of INV-17
Table Major Company List of GSK-2981278
Table Major Company List of BBI-6000
Table Major Company List of Others
Table Global Nuclear Receptor ROR-Gamma Market 2013-2018, by Type, in USD Million
Table Global Nuclear Receptor ROR-Gamma Market Forecast 2019-2024, by Type, in USD Million
Table 4SC AG Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of 4SC AG (Sales Revenue, Cost, Gross Margin)
Table Advinus Therapeutics Ltd. Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Advinus Therapeutics Ltd. (Sales Revenue, Cost, Gross Margin)
Table Arrien Pharmaceuticals, LLC Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Arrien Pharmaceuticals, LLC (Sales Revenue, Cost, Gross Margin)
Table Aurigene Discovery Technologies Limited Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Aurigene Discovery Technologies Limited (Sales Revenue, Cost, Gross Margin)
Table Biogen, Inc. Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Biogen, Inc. (Sales Revenue, Cost, Gross Margin)
Table Brickell Biotech, Inc. Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Brickell Biotech, Inc. (Sales Revenue, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Celgene Corporation (Sales Revenue, Cost, Gross Margin)
Table Genentech, Inc. Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Genentech, Inc. (Sales Revenue, Cost, Gross Margin)
Table Genfit SA Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Genfit SA (Sales Revenue, Cost, Gross Margin)
Table GlaxoSmithKline Plc Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of GlaxoSmithKline Plc (Sales Revenue, Cost, Gross Margin)
Table Hanmi Pharmaceuticals, Co. Ltd. Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Hanmi Pharmaceuticals, Co. Ltd. (Sales Revenue, Cost, Gross Margin)
Table Karo Bio AB Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Karo Bio AB (Sales Revenue, Cost, Gross Margin)
Table Lead Pharma Holding B.V. Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Lead Pharma Holding B.V. (Sales Revenue, Cost, Gross Margin)
Table Nuevolution AB Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Nuevolution AB (Sales Revenue, Cost, Gross Margin)
Table Phenex Pharmaceuticals AG Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Phenex Pharmaceuticals AG (Sales Revenue, Cost, Gross Margin)
Table Reata Pharmaceuticals, Inc. Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Reata Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)
Table Teijin Pharma Limited Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Teijin Pharma Limited (Sales Revenue, Cost, Gross Margin)
Table Visionary Pharmaceuticals, Inc. Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Visionary Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)
Table Vitae Pharmaceuticals, Inc. Overview List
Table Nuclear Receptor ROR-Gamma Business Operation of Vitae Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)
Table Global Nuclear Receptor ROR-Gamma Sales Revenue 2013-2018, by Company, in USD Million
Table Global Nuclear Receptor ROR-Gamma Sales Revenue Share, by Company, in USD Million
Table Nuclear Receptor ROR-Gamma Demand in Hospital, 2013-2018, in USD Million
Table Major Consumers in Hospital
Table Nuclear Receptor ROR-Gamma Demand in Clinic, 2013-2018, in USD Million
Table Major Consumers in Clinic
Table Nuclear Receptor ROR-Gamma Demand in Others, 2013-2018, in USD Million
Table Major Consumers in Others
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Nuclear Receptor ROR-Gamma Demand Forecast 2019-2024, by Application, in USD Million
Table Nuclear Receptor ROR-Gamma Production 2013-2018, by Region, in USD Million
Table Global Nuclear Receptor ROR-Gamma Market 2013-2018, by Region, in USD Million
Table Global Nuclear Receptor ROR-Gamma Market Share 2013-2018, by Region, in USD Million
Table North America Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million
Table Europe Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million
Table South America Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Nuclear Receptor ROR-Gamma Market Size 2013-2018, by Country, in USD Million
Table Nuclear Receptor ROR-Gamma Market Forecast 2019-2024, by Region, in USD Million
Table Price Factors List
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.